secwatch.observer — SEC 8-K summary
======================================

Issuer:     Accelerate Diagnostics, Inc (—)
CIK:        0000727207
Form:       8-K
Filed at:   2025-04-15T23:59:59+00:00
Accession:  0001104659-25-035184
Event type: leadership
Sentiment:  neutral
Materiality: 0.70
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Accelerate Diagnostics adds Shalhoub, Nathan to board; forms strategic alternatives committee
--------------------------------------------------------------------------------

- Elected Paul Shalhoub and Gilbert Nathan as independent directors effective April 10, 2025; each receives $25k monthly cash fee.
- Board formed a Special Committee (Burris, Shalhoub, Nathan) to oversee strategic alternatives to maximize value, no assurances given.
- Approved retention bonuses: CFO David Patience $159,650 and CTO Lawrence Mertz $171,458, payable soon with 180-day clawback.
- Nathan appointed per director nomination rights from note purchase agreement related to 16% Super-Priority Senior Secured PIK Notes due 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/727207/000110465925035184/0001104659-25-035184-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/727207/000110465925035184/tm2512407d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-035184

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer